HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sheng-Wei Jin Selected Research

resolvin D1

4/2014Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na,K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sheng-Wei Jin Research Topics

Disease

15Inflammation (Inflammations)
01/2024 - 01/2013
10Lung Injury
01/2022 - 01/2013
10Acute Lung Injury
11/2021 - 02/2007
9Sepsis (Septicemia)
03/2024 - 01/2018
7Pulmonary Edema
01/2024 - 02/2007
4Edema (Dropsy)
01/2024 - 02/2007
4Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022 - 04/2018
2Cardiomyopathies (Cardiomyopathy)
03/2024 - 01/2021
1Wounds and Injuries (Trauma)
10/2023
1Traumatic Brain Injuries (Traumatic Brain Injury)
10/2023
1Septic Shock (Toxic Shock Syndrome)
10/2022
1Pneumonia (Pneumonitis)
07/2021
1Necrosis
06/2021
1Endotoxemia
01/2021
1Gram-Negative Bacterial Infections
01/2020
1Infections
01/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Ankylosing Spondylitis
01/2015
1Hypoxia (Hypoxemia)
07/2014
1Obstructive Sleep Apnea
07/2014

Drug/Important Bio-Agent (IBA)

16LipopolysaccharidesIBA
11/2021 - 02/2007
6LipidsIBA
01/2022 - 11/2015
5Adenosine Triphosphatases (ATPase)IBA
11/2021 - 05/2013
5lipoxin A4IBA
08/2019 - 02/2007
4Epithelial Sodium ChannelsIBA
11/2021 - 05/2013
4LipoxinsIBA
08/2019 - 01/2013
3CD59 AntigensIBA
01/2023 - 04/2018
310,17- dihydroxydocosa- 4,7,11,13,15,19- hexaenoic acidIBA
01/2022 - 01/2018
3CytokinesIBA
07/2021 - 01/2018
3Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2007
2Biomarkers (Surrogate Marker)IBA
10/2023 - 10/2022
2Caspase 3 (Caspase-3)IBA
11/2021 - 08/2019
2Docosahexaenoic AcidsIBA
11/2021 - 01/2017
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2021 - 02/2007
2Sirtuin 1IBA
07/2021 - 10/2020
2Interleukin-6 (Interleukin 6)IBA
07/2021 - 01/2013
2Sodium Channels (Sodium Channel)IBA
01/2021 - 12/2020
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2018 - 02/2007
1Indicators and Reagents (Reagents)IBA
03/2024
1CaspasesIBA
03/2024
1resolvin D2IBA
03/2024
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
01/2024
1CC ChemokinesIBA
01/2024
1Vascular Endothelial Growth Factor CIBA
01/2024
1LigandsIBA
01/2024
1Syndecan-1 (Syndecan 1)IBA
10/2023
1InflammasomesIBA
01/2023
1Anti-Bacterial Agents (Antibiotics)IBA
10/2022
15S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA
01/2022
1Prostaglandin D2IBA
01/2022
1Pathogen-Associated Molecular Pattern MoleculesIBA
01/2022
1ZymosanIBA
06/2021
1DexmedetomidineFDA Link
06/2021
1InterleukinsIBA
06/2021
1Neutralizing AntibodiesIBA
06/2021
1Rosuvastatin Calcium (Crestor)FDA Link
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Linoleic Acid (Linoleate)IBA
01/2020
1AlbuminsIBA
01/2020
1Carbon MonoxideIBA
04/2018
1Annexin A1IBA
04/2018
1Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
04/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018
17,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA
01/2018
1Lactic Acid (Lactate)FDA LinkGeneric
01/2018
1Cyclic AMP (AMP, Cyclic)IBA
01/2018
1MicroRNAs (MicroRNA)IBA
11/2015
1Fatty Acids (Saturated Fatty Acids)IBA
01/2015
1EnzymesIBA
07/2014
1Inositol (Myoinositol)IBA
07/2014
1Transcription Factor CHOPIBA
07/2014
1Phosphotransferases (Kinase)IBA
07/2014
1salubrinalIBA
07/2014
1resolvin D1IBA
04/2014
1S 6 (S-6)IBA
05/2013
1phenylalanylleucineIBA
05/2013
1Oleic Acid (Oleate)IBA
05/2013
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2007
1Heme Oxygenase-1IBA
02/2007
1Malondialdehyde (Propanedial)IBA
02/2007

Therapy/Procedure

3Therapeutics
10/2022 - 01/2017
1Resuscitation
10/2022
1Punctures
01/2018
1Ligation
01/2018